- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT04217863
To Observe the Psychophysiological Alterations in Traumatic Stress Subjects
Effects of the Guided Disclosure Protocol on Post-Traumatic Growth: A Randomized Control Trial Designed to Observe Psychophysiological Alterations in Traumatic Stress Subjects
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
Study design:
The study will be conducted as multicenter randomized controlled trial. On the basis of eligibility criteria subjects providing consent to participate in the study will be randomized into two groups, experimental group including those who receive the intervention and a control group receiving control intervention. The study outcomes will be monitored in subjects of both groups at different intervals i.e. at baseline and at 3-month follow-up (post-interventional).
Participants Subjects for the present study will be recruited from 5 centers (based in Karachi, Pakistan). The targeted population includes subjects from diverse ethnicity and considered eligible for participation in the study if they indicated in a pre-screening form that they had experienced traumatic event. These subjects will be invited to participate in the study through advertisement on notice board of each center. A written informed consent will be obtained from each study subject after providing detailed information regarding objectives of the study and its duration.
Interventions
The experimental intervention (GDP):
It includes three writing sessions of 20 minutes where the participants will be made to recall the facts regarding the traumatic event first and then the emotions triggered related to the revealed facts will be channelized. The information related to the immediate priority changes due to the revival of the traumatic history and its reflection on current feelings will be collected. Moreover, the learned coping mechanisms will also be inquired and how the traumatic event altered their vision and their personalities and how it helps in coping with future difficulties.
The original instructions will be translated into local language and altered according to the specific traumatic experience.
In the following, a fusion of the tasks concerning each of the three writing sessions is shown.
- Participants will be required to describe memories associated with traumatic event in a sequential order, with an objective and detached attitude
They will be asked to describe
- Their opinion regarding the traumatic event and emotions perceived during the experience
- Its impact on their daily lives, and how it has altered their attitudes toward life.
The actual situation will be focused, while reviving the whole traumatic event experience which aids in exploring the following aspects:
- Present thoughts and feelings regarding the traumatic experience, and also clarify the differences between the ones felt at the time of traumatic event in comparison to the current feelings.
- How much they understand and appreciate themselves for successfully dealing with the traumatic event
- To what extent the traumatic event has modified their vision, attitude, knowledge, and skills, and how it can help in their future;
- What will be their future reactions to other similar events. For the writing session it is mandatory to maintain standard experimental environment with maximum silence so that the subject can write peacefully without getting disturbed. Two weeks after the initial assessment, the first writing session will be performed followed by two sessions once every 2 weeks.
The control intervention:
In control intervention the subjects will be required to take three 20-minute writing sessions, in which they will be asked to write about their daily events of the past week, the writing must focus on the facts and highlight an objective and detached attitude. It has shown potential improvements after the guided disclosure protocol (GDP). Works through the placebo effect. Same protocol will be followed for these subjects as the one used for GDP.
A day prior to each writing session, in both conditions either experimental or control the researcher will communicate with each study subject via telephone in order to give them a reminder to perform the writing task and to check their understanding regarding the instructions given in the booklet. Details regarding the inability to contact the subject will also be recorded in the patient form.
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Sindh
-
Karachi, Sindh, Pákistán, 78500
- Shamoon Noushad
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Must be disease free, there must be no evidence of any metastatic disease
- Property of written and spoken the English language.
- Experienced any traumatic event in the last 12 Months
Exclusion Criteria:
- Subjects who received a structured psychological intervention for at least 6 months during the last 3 years performed by a psychologist or psychiatrist will be excluded.
- Those with a codified psychiatric disorder (according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) who received Psychopharmacological treatment during the last 3 years will also be excluded from the study sample.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Podpůrná péče
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: The experimental intervention (GDP): It includes three writing
|
Guided Disclosure Protocol
|
|
Žádný zásah: The control intervention:
A day prior to each writing session, the researcher will communicate with each study subject via telephone in order to give them a reminder to perform the writing task and to check their understanding regarding the instructions given in the booklet.
Details regarding the inability to contact the subject will also be recorded in the patient form.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Post-Traumatic Growth (PTG)
Časové okno: 3 Months
|
Change in the Post-traumatic Growth Inventory (PTGI) will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
C- Reactive Protein (CRP)
Časové okno: 3 Months
|
Change in the CRP level will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
|
Brain-derived neurotrophic factor (BDNF)
Časové okno: 3 Months
|
Change in the BDNF level will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
|
Interleukin-6 (IL-6)
Časové okno: 3 Months
|
Change in the IL-6 level will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
|
Glutamate
Časové okno: 3 Months
|
Change in the Glutamate level will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
|
Cortisol
Časové okno: 3 Months
|
Change in the Cortisol level will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
|
Alpha waves
Časové okno: 3 Months
|
Change in the Brain waves (Alpha waves) will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
|
Heart Rate Variability
Časové okno: 3 Months
|
Change in the Heart Rate Variability will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
|
Beta waves
Časové okno: 3 Months
|
Change in the Brain waves (Beta waves) will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
Další výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Trauma Symptom Checklist 40 (TSC-40)
Časové okno: 3 Months
|
Change in the Trauma Symptom Checklist 40 (TSC-40) will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
|
Traumatic Stress Scale (Sadaf Stress Scale)
Časové okno: 3 Months
|
Change in the Traumatic Stress Scale will be observed among the subjects enrolled in the GDP group as compared to the control group.
|
3 Months
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Publikace a užitečné odkazy
Obecné publikace
- Gandubert C, Scali J, Ancelin ML, Carriere I, Dupuy AM, Bagnolini G, Ritchie K, Sebanne M, Martrille L, Baccino E, Hermes A, Attal J, Chaudieu I. Biological and psychological predictors of posttraumatic stress disorder onset and chronicity. A one-year prospective study. Neurobiol Stress. 2016 Feb 4;3:61-67. doi: 10.1016/j.ynstr.2016.02.002. eCollection 2016 Jun.
- Kalisch R, Muller MB, Tuscher O. A conceptual framework for the neurobiological study of resilience. Behav Brain Sci. 2015;38:e92. doi: 10.1017/S0140525X1400082X. Epub 2014 Aug 27.
- Cai WP, Pan Y, Zhang SM, Wei C, Dong W, Deng GH. Relationship between cognitive emotion regulation, social support, resilience and acute stress responses in Chinese soldiers: Exploring multiple mediation model. Psychiatry Res. 2017 Oct;256:71-78. doi: 10.1016/j.psychres.2017.06.018. Epub 2017 Jun 8.
- Liu AN, Wang LL, Li HP, Gong J, Liu XH. Correlation Between Posttraumatic Growth and Posttraumatic Stress Disorder Symptoms Based on Pearson Correlation Coefficient: A Meta-Analysis. J Nerv Ment Dis. 2017 May;205(5):380-389. doi: 10.1097/NMD.0000000000000605.
- Linz R, Puhlmann LMC, Apostolakou F, Mantzou E, Papassotiriou I, Chrousos GP, Engert V, Singer T. Acute psychosocial stress increases serum BDNF levels: an antagonistic relation to cortisol but no group differences after mental training. Neuropsychopharmacology. 2019 Sep;44(10):1797-1804. doi: 10.1038/s41386-019-0391-y. Epub 2019 Apr 16.
- Alper B, Erdogan B, Erdogan MO, Bozan K, Can M. Associations of Trauma Severity with Mean Platelet Volume and Levels of Systemic Inflammatory Markers (IL1beta, IL6, TNFalpha, and CRP). Mediators Inflamm. 2016;2016:9894716. doi: 10.1155/2016/9894716. Epub 2016 Apr 5.
- Smith HE, Jones CJ, Hankins M, Field A, Theadom A, Bowskill R, Horne R, Frew AJ. The effects of expressive writing on lung function, quality of life, medication use, and symptoms in adults with asthma: a randomized controlled trial. Psychosom Med. 2015 May;77(4):429-37. doi: 10.1097/PSY.0000000000000166.
- Gidron Y, Duncan E, Lazar A, Biderman A, Tandeter H, Shvartzman P. Effects of guided written disclosure of stressful experiences on clinic visits and symptoms in frequent clinic attenders. Fam Pract. 2002 Apr;19(2):161-6. doi: 10.1093/fampra/19.2.161.
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další identifikační čísla studie
- KU-Psychophysiology-5
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na GDP
-
Cancer Institute and Hospital, Chinese Academy...Neznámý
-
Cancer Institute and Hospital, Chinese Academy...DokončenoExtranodální NK/T-buněčný lymfom stadia I/IIČína
-
Shandong Provincial HospitalNeznámýHepatosplenický T-buněčný lymfom | Periferní T-buněčný lymfom, jinak nespecifikovaný | ALK-negativní anaplastický velkobuněčný lymfom | Angioimunoblastický T buněčný lymfom | Enteropathy Associated T Cell Lymfoma | Subkutánní panikulitida jako T-buněčný lymfomČína
-
Cairo UniversityDokončenoRecidivující klasický Hodgkinův lymfomEgypt